Biotechnology
The Biotechnology industry has a total of 587 stocks, with a combined market cap of $1.12 trillion and total revenue of $110.01 billion.
Market Cap
1.12T
Revenue
110.01B
Profits
-41.29B
PE Ratio
n/a
Profit Margin
-37.53%
Dividend Yield
0.04%
587 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 110.07B | 0.03% | 1,144,201 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 64.83B | -0.84% | 739,785 | 14.92B |
| 3 | ARGX | argenx SE | 50.57B | -1.33% | 143,320 | 4.74B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 39.65B | -1.17% | 386,517 | 4.29B |
| 5 | ONC | BeOne Medicines AG | 34.36B | -0.18% | 139,429 | 5.70B |
| 6 | RVMD | Revolution Medicines, Inc. | 32.34B | -1.04% | 1,362,316 | - |
| 7 | RPRX | Royalty Pharma plc | 31.37B | 1.74% | 2,260,853 | 2.44B |
| 8 | BNTX | BioNTech SE | 23.37B | 1.62% | 512,668 | 3.23B |
| 9 | INSM | Insmed Incorporated | 23.16B | -2.43% | 1,535,252 | 819.56M |
| 10 | ROIV | Roivant Sciences Ltd. | 21.74B | -2.14% | 3,721,197 | 8.26M |
| 11 | INCY | Incyte Corporation | 19.45B | -0.05% | 425,582 | 5.36B |
| 12 | MRNA | Moderna, Inc. | 18.64B | -0.61% | 2,789,107 | 2.23B |
| 13 | GMAB | Genmab A/S | 16.39B | -0.59% | 1,028,798 | 3.90B |
| 14 | ASND | Ascendis Pharma A/S | 15.41B | 0.22% | 368,354 | 998.25M |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 15.03B | 0.08% | 397,576 | 4.44B |
| 16 | BBIO | BridgeBio Pharma, Inc. | 13.54B | -1.61% | 1,291,909 | 579.96M |
| 17 | SMMT | Summit Therapeutics Inc. | 12.83B | -5.41% | 5,436,365 | - |
| 18 | EXEL | Exelixis, Inc. | 12.61B | 1.07% | 980,084 | 2.38B |
| 19 | IONS | Ionis Pharmaceuticals, Inc. | 12.52B | - | 932,284 | 1.06B |
| 20 | AXSM | Axsome Therapeutics, Inc. | 12.14B | 0.97% | 397,057 | 708.24M |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.97B | 1.06% | 106,940 | 1.13B |
| 22 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.61B | -0.29% | 658,226 | 622.01M |
| 23 | CYTK | Cytokinetics, Incorporated | 10.42B | -1.69% | 633,989 | 105.82M |
| 24 | BMRN | BioMarin Pharmaceutical Inc. | 10.40B | -0.52% | 1,290,039 | 3.24B |
| 25 | ABVX | ABIVAX Société Anonyme | 9.70B | -1.95% | 988,384 | 5.37M |
| 26 | PRAX | Praxis Precision Medicines, Inc. | 9.57B | -2.04% | 176,226 | 7.46M |
| 27 | KRYS | Krystal Biotech, Inc. | 8.81B | -1.75% | 92,097 | 417.30M |
| 28 | HALO | Halozyme Therapeutics, Inc. | 8.09B | -0.45% | 760,108 | 1.51B |
| 29 | NUVL | Nuvalent, Inc. | 8.04B | 0.55% | 368,685 | - |
| 30 | IBRX | ImmunityBio, Inc. | 7.56B | -6.72% | 15,055,438 | 140.98M |
| 31 | TECH | Bio-Techne Corporation | 7.55B | 1.75% | 1,730,817 | 1.21B |
| 32 | IMVT | Immunovant, Inc. | 7.02B | 0.21% | 1,215,407 | - |
| 33 | CELC | Celcuity Inc. | 6.82B | -1.95% | 477,221 | - |
| 34 | PCVX | Vaxcyte, Inc. | 6.81B | -0.49% | 875,935 | - |
| 35 | KYMR | Kymera Therapeutics, Inc. | 6.48B | -2.30% | 284,099 | 51.48M |
| 36 | CORT | Corcept Therapeutics Incorporated | 6.45B | 0.66% | 273,274 | 769.10M |
| 37 | PTGX | Protagonist Therapeutics, Inc. | 6.40B | -2.40% | 198,424 | 74.06M |
| 38 | SYRE | Spyre Therapeutics, Inc. | 6.38B | -1.13% | 381,211 | - |
| 39 | CNTA | Centessa Pharmaceuticals plc | 6.15B | -0.15% | 573,667 | 15.00M |
| 40 | APGE | Apogee Therapeutics, Inc. | 6.10B | -1.23% | 215,065 | - |
| 41 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.04B | -2.28% | 127,980 | 217.17M |
| 42 | MIRM | Mirum Pharmaceuticals, Inc. | 6.01B | -2.11% | 290,020 | 569.61M |
| 43 | SRRK | Scholar Rock Holding Corporation | 5.78B | 1.03% | 523,613 | - |
| 44 | PTCT | PTC Therapeutics, Inc. | 5.70B | -1.59% | 453,682 | 827.11M |
| 45 | CGON | CG Oncology, Inc. | 5.69B | -0.09% | 343,994 | 5.07M |
| 46 | COGT | Cogent Biosciences, Inc. | 5.61B | 0.78% | 1,415,199 | - |
| 47 | TGTX | TG Therapeutics, Inc. | 5.47B | -1.63% | 826,909 | 700.35M |
| 48 | LEGN | Legend Biotech Corporation | 5.42B | 4.18% | 1,377,369 | 1.14B |
| 49 | BLTE | Belite Bio, Inc | 5.41B | -4.73% | 93,165 | - |
| 50 | XENE | Xenon Pharmaceuticals Inc. | 5.25B | 0.28% | 654,494 | 7.50M |
| 51 | CRSP | CRISPR Therapeutics AG | 4.84B | 0.48% | 1,186,560 | 4.10M |
| 52 | DNTH | Dianthus Therapeutics, Inc. | 4.76B | -2.87% | 339,663 | 1.34M |
| 53 | LGND | Ligand Pharmaceuticals Incorporated | 4.57B | 2.52% | 308,128 | 274.48M |
| 54 | CAI | Caris Life Sciences, Inc. | 4.41B | -2.20% | 1,247,645 | 907.29M |
| 55 | MANE | Veradermics, Incorporated | 4.18B | -3.03% | 164,124 | - |
| 56 | NAMS | NewAmsterdam Pharma Company N.V. | 4.14B | -0.92% | 410,958 | 22.57M |
| 57 | TVTX | Travere Therapeutics, Inc. | 4.13B | -0.63% | 477,982 | 536.20M |
| 58 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.87B | -0.97% | 505,910 | 18.07M |
| 59 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.82B | -0.10% | 1,054,963 | 596.96M |
| 60 | ORKA | Oruka Therapeutics, Inc. | 3.65B | 3.05% | 649,786 | - |
| 61 | ACAD | ACADIA Pharmaceuticals Inc. | 3.62B | -0.84% | 837,752 | 1.10B |
| 62 | VKTX | Viking Therapeutics, Inc. | 3.56B | -0.10% | 821,728 | - |
| 63 | ERAS | Erasca, Inc. | 3.50B | -2.89% | 1,766,799 | - |
| 64 | EWTX | Edgewise Therapeutics, Inc. | 3.48B | -0.95% | 301,302 | - |
| 65 | TLX | Telix Pharmaceuticals Limited | 3.22B | -7.45% | 212,302 | 803.79M |
| 66 | DNLI | Denali Therapeutics Inc. | 2.99B | -2.23% | 2,545,639 | - |
| 67 | RCUS | Arcus Biosciences, Inc. | 2.95B | -1.72% | 286,035 | 236.00M |
| 68 | RLAY | Relay Therapeutics, Inc. | 2.95B | -1.02% | 2,446,534 | 10.68M |
| 69 | TNGX | Tango Therapeutics, Inc. | 2.94B | -6.01% | 1,080,716 | 56.99M |
| 70 | DYN | Dyne Therapeutics, Inc. | 2.88B | 0.46% | 994,438 | - |
| 71 | BEAM | Beam Therapeutics Inc. | 2.85B | 3.51% | 956,318 | 164.01M |
| 72 | ALMS | Alumis Inc. | 2.79B | -1.31% | 315,320 | 8.40M |
| 73 | GPCR | Structure Therapeutics Inc. | 2.78B | 0.67% | 572,485 | - |
| 74 | KLRA | Kailera Therapeutics, Inc. | 2.74B | 0.52% | 220,771 | - |
| 75 | TARS | Tarsus Pharmaceuticals, Inc. | 2.69B | -1.39% | 163,817 | 535.08M |
| 76 | ARQT | Arcutis Biotherapeutics, Inc. | 2.59B | -1.52% | 599,722 | 415.62M |
| 77 | IDYA | IDEAYA Biosciences, Inc. | 2.56B | -1.49% | 220,364 | 225.27M |
| 78 | IRON | Disc Medicine, Inc. | 2.55B | -0.64% | 146,116 | - |
| 79 | ELVN | Enliven Therapeutics, Inc. | 2.54B | -1.44% | 499,816 | - |
| 80 | MLYS | Mineralys Therapeutics, Inc. | 2.47B | -0.83% | 527,403 | - |
| 81 | IMNM | Immunome, Inc. | 2.46B | -5.53% | 684,717 | 4.02M |
| 82 | DFTX | Definium Therapeutics, Inc. | 2.45B | -0.97% | 702,271 | - |
| 83 | VERA | Vera Therapeutics, Inc. | 2.44B | -0.93% | 243,505 | - |
| 84 | CLDX | Celldex Therapeutics, Inc. | 2.41B | 0.46% | 284,649 | 865.00K |
| 85 | RARE | Ultragenyx Pharmaceutical Inc. | 2.29B | -1.48% | 501,316 | 670.00M |
| 86 | KOD | Kodiak Sciences Inc. | 2.27B | -2.99% | 178,841 | - |
| 87 | NKTR | Nektar Therapeutics | 2.25B | -2.57% | 373,881 | 55.63M |
| 88 | ZLAB | Zai Lab Limited | 2.08B | -2.93% | 262,218 | 453.28M |
| 89 | TRVI | Trevi Therapeutics, Inc. | 2.01B | -0.14% | 644,946 | - |
| 90 | AUPH | Aurinia Pharmaceuticals Inc. | 1.96B | -1.29% | 728,389 | 298.30M |
| 91 | MESO | Mesoblast Limited | 1.96B | 1.37% | 98,917 | 65.38M |
| 92 | AAPG | Ascentage Pharma Group International | 1.96B | 1.31% | 7,822 | 82.08M |
| 93 | PHVS | Pharvaris N.V. | 1.95B | -2.16% | 201,531 | - |
| 94 | TYRA | Tyra Biosciences, Inc. | 1.92B | -2.30% | 190,202 | - |
| 95 | ADMA | ADMA Biologics, Inc. | 1.90B | -3.01% | 1,883,141 | 509.86M |
| 96 | VRDN | Viridian Therapeutics, Inc. | 1.90B | -2.77% | 2,219,611 | 70.92M |
| 97 | NBTX | Nanobiotix S.A. | 1.88B | 3.21% | 48,524 | 38.27M |
| 98 | ZYME | Zymeworks Inc. | 1.86B | 1.51% | 262,916 | 81.26M |
| 99 | GENB | Generate Biomedicines, Inc. | 1.86B | 3.79% | 643,221 | 30.30M |
| 100 | SION | Sionna Therapeutics, Inc. | 1.85B | -1.90% | 118,147 | - |
| 101 | STOK | Stoke Therapeutics, Inc. | 1.84B | -0.57% | 218,705 | 32.08M |
| 102 | IOVA | Iovance Biotherapeutics, Inc. | 1.84B | 11.08% | 19,306,537 | 285.61M |
| 103 | LKFT | Lakefront Biotherapeutics NV | 1.83B | -0.97% | 91,327 | 1.20B |
| 104 | RAPP | Rapport Therapeutics, Inc. | 1.80B | 2.40% | 100,991 | 20.00M |
| 105 | NRIX | Nurix Therapeutics, Inc. | 1.80B | -0.86% | 633,052 | 71.78M |
| 106 | VCEL | Vericel Corporation | 1.79B | -0.11% | 205,535 | 292.09M |
| 107 | OCUL | Ocular Therapeutix, Inc. | 1.78B | -1.16% | 1,323,494 | 52.04M |
| 108 | SRPT | Sarepta Therapeutics, Inc. | 1.77B | -1.12% | 1,250,841 | 2.18B |
| 109 | SNDX | Syndax Pharmaceuticals, Inc. | 1.76B | 0.40% | 723,025 | 217.17M |
| 110 | ANAB | AnaptysBio, Inc. | 1.75B | -0.26% | 235,421 | 232.39M |
| 111 | OCS | Oculis Holding AG | 1.75B | -4.79% | 428,329 | 1.40M |
| 112 | NTLA | Intellia Therapeutics, Inc. | 1.74B | 0.93% | 2,548,607 | 66.09M |
| 113 | HRMY | Harmony Biosciences Holdings, Inc. | 1.74B | -1.25% | 229,860 | 899.11M |
| 114 | AGIO | Agios Pharmaceuticals, Inc. | 1.68B | -2.15% | 332,431 | 66.05M |
| 115 | CAPR | Capricor Therapeutics, Inc. | 1.66B | -3.08% | 391,588 | 11.13M |
| 116 | INVA | Innoviva, Inc. | 1.66B | 1.08% | 976,448 | 420.69M |
| 117 | NUVB | Nuvation Bio Inc. | 1.65B | -1.36% | 3,385,499 | 143.05M |
| 118 | PVLA | Palvella Therapeutics, Inc. | 1.64B | -1.32% | 104,669 | - |
| 119 | ATAI | AtaiBeckley Inc. | 1.59B | 0.12% | 4,196,563 | 3.49M |
| 120 | RXRX | Recursion Pharmaceuticals, Inc. | 1.59B | -3.70% | 11,776,985 | 66.41M |
| 121 | GLUE | Monte Rosa Therapeutics, Inc. | 1.59B | -0.42% | 706,489 | 42.95M |
| 122 | ABCL | AbCellera Biologics Inc. | 1.58B | 0.88% | 5,531,656 | 79.21M |
| 123 | IMTX | Immatics N.V. | 1.58B | 6.24% | 266,096 | 43.00M |
| 124 | TSHA | Taysha Gene Therapies, Inc. | 1.57B | -1.26% | 896,386 | 7.47M |
| 125 | VIR | Vir Biotechnology, Inc. | 1.54B | 0.89% | 782,918 | 65.50M |
| 126 | QURE | uniQure N.V. | 1.53B | -1.82% | 454,251 | 18.09M |
| 127 | GHRS | GH Research PLC | 1.53B | 2.23% | 278,459 | - |
| 128 | MBX | MBX Biosciences, Inc. | 1.52B | 0.60% | 301,199 | - |
| 129 | DMRA | Damora Therapeutics, Inc. | 1.51B | 0.92% | 123,002 | - |
| 130 | ARDX | Ardelyx, Inc. | 1.51B | -3.62% | 1,511,697 | 427.68M |
| 131 | PGEN | Precigen, Inc. | 1.51B | -0.93% | 1,228,413 | 31.60M |
| 132 | INBX | Inhibrx Biosciences, Inc. | 1.50B | -7.72% | 508,134 | 1.30M |
| 133 | NVAX | Novavax, Inc. | 1.50B | 1.34% | 3,330,270 | 596.34M |
| 134 | IMCR | Immunocore Holdings plc | 1.48B | -3.33% | 606,827 | 412.81M |
| 135 | SLS | SELLAS Life Sciences Group, Inc. | 1.43B | 1.65% | 9,868,542 | - |
| 136 | BHVN | Biohaven Ltd. | 1.43B | 0.05% | 873,046 | - |
| 137 | MAZE | Maze Therapeutics, Inc. | 1.43B | 0.16% | 288,987 | 20.00M |
| 138 | KALV | KalVista Pharmaceuticals, Inc. | 1.43B | 0.07% | 974,320 | 114.48M |
| 139 | BCAX | Bicara Therapeutics Inc. | 1.42B | 3.41% | 183,302 | - |
| 140 | URGN | UroGen Pharma Ltd. | 1.41B | -3.31% | 218,310 | 140.49M |
| 141 | MLTX | MoonLake Immunotherapeutics | 1.32B | -2.22% | 411,916 | - |
| 142 | MPLT | MapLight Therapeutics, Inc. | 1.30B | -2.02% | 98,969 | - |
| 143 | SEPN | Septerna, Inc. | 1.29B | 2.76% | 268,351 | 72.26M |
| 144 | SVRA | Savara Inc. | 1.27B | -0.99% | 377,925 | - |
| 145 | FTRE | Fortrea Holdings Inc. | 1.26B | 1.22% | 505,525 | 2.71B |
| 146 | AVBP | ArriVent BioPharma, Inc. | 1.25B | -0.96% | 274,791 | - |
| 147 | WVE | Wave Life Sciences Ltd. | 1.22B | -1.48% | 1,444,715 | 71.80M |
| 148 | ZBIO | Zenas BioPharma, Inc. | 1.20B | -4.18% | 201,030 | 10.00M |
| 149 | AVLN | Avalyn Pharma Inc. | 1.19B | 0.21% | 256,182 | - |
| 150 | OLMA | Olema Pharmaceuticals, Inc. | 1.19B | -3.13% | 763,571 | - |
| 151 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.14B | -1.79% | 1,458,231 | 204.73M |
| 152 | AKTS | Aktis Oncology, Inc. | 1.13B | 6.80% | 95,907 | 8.28M |
| 153 | COAG | Hemab Therapeutics Holdings, Inc. | 1.12B | -3.52% | 68,314 | - |
| 154 | JBIO | Jade Biosciences, Inc. | 1.10B | -4.99% | 252,440 | - |
| 155 | DBVT | DBV Technologies S.A. | 1.10B | -2.80% | 64,404 | 5.74M |
| 156 | EYPT | EyePoint, Inc. | 1.09B | 1.41% | 562,372 | 7.61M |
| 157 | CRVS | Corvus Pharmaceuticals, Inc. | 1.07B | -2.83% | 846,733 | - |
| 158 | IVA | Inventiva S.A. | 1.06B | -2.69% | 149,004 | 7.94M |
| 159 | MNKD | MannKind Corporation | 1.03B | 0.91% | 3,439,934 | 360.78M |
| 160 | KURA | Kura Oncology, Inc. | 991.61M | 0.36% | 1,931,814 | 71.64M |
| 161 | LXRX | Lexicon Pharmaceuticals, Inc. | 959.26M | -3.14% | 1,433,789 | 69.64M |
| 162 | SPTX | Seaport Therapeutics, Inc. | 917.38M | 0.64% | 164,477 | - |
| 163 | PHAR | Pharming Group N.V. | 915.65M | -0.86% | 17,158 | 369.49M |
| 164 | PHAT | Phathom Pharmaceuticals, Inc. | 901.53M | -1.99% | 511,732 | 204.89M |
| 165 | DRTS | Alpha Tau Medical Ltd. | 885.38M | -8.21% | 790,309 | - |
| 166 | JANX | Janux Therapeutics, Inc. | 884.27M | 0.62% | 257,750 | 13.73M |
| 167 | ANNX | Annexon, Inc. | 869.18M | -2.48% | 1,606,119 | - |
| 168 | ABUS | Arbutus Biopharma Corporation | 866.20M | -1.24% | 583,311 | 191.45M |
| 169 | SANA | Sana Biotechnology, Inc. | 862.70M | -1.59% | 3,413,032 | - |
| 170 | ORIC | ORIC Pharmaceuticals, Inc. | 858.16M | -2.01% | 455,836 | - |
| 171 | MGTX | MeiraGTx Holdings plc | 852.93M | -2.95% | 241,017 | 79.76M |
| 172 | TBPH | Theravance Biopharma, Inc. | 846.76M | 0.52% | 168,956 | 109.78M |
| 173 | CGEM | Cullinan Therapeutics, Inc. | 841.98M | -2.00% | 274,093 | - |
| 174 | AURA | Aura Biosciences, Inc. | 841.58M | -0.26% | 184,897 | - |
| 175 | ODTX | Odyssey Therapeutics, Inc. | 836.40M | -0.06% | 252,943 | 2.98M |
| 176 | OMER | Omeros Corporation | 835.94M | -3.43% | 1,037,650 | 9.89M |
| 177 | XNCR | Xencor, Inc. | 833.35M | -0.27% | 277,070 | 97.36M |
| 178 | CTMX | CytomX Therapeutics, Inc. | 819.65M | 0.13% | 1,410,187 | 35.54M |
| 179 | DRUG | Bright Minds Biosciences Inc. | 818.12M | -0.10% | 253,578 | - |
| 180 | EVMN | Evommune, Inc. | 810.41M | -4.46% | 321,872 | 10.00M |
| 181 | LBRX | LB Pharmaceuticals Inc | 810.40M | 0.93% | 107,237 | - |
| 182 | GERN | Geron Corporation | 805.11M | -0.40% | 4,545,462 | 196.12M |
| 183 | SPRY | ARS Pharmaceuticals, Inc. | 804.36M | -1.58% | 1,537,824 | 98.99M |
| 184 | AVTX | Avalo Therapeutics, Inc. | 795.20M | -2.35% | 1,111,403 | 59.00K |
| 185 | ABSI | Absci Corporation | 788.88M | -0.59% | 1,585,270 | 1.84M |
| 186 | VOR | Vor Biopharma Inc. | 777.57M | -4.59% | 509,681 | - |
| 187 | ANRO | Alto Neuroscience, Inc. | 742.42M | -1.67% | 197,117 | - |
| 188 | RLMD | Relmada Therapeutics, Inc. | 739.46M | -2.22% | 514,473 | - |
| 189 | TENX | Tenax Therapeutics, Inc. | 712.43M | -2.10% | 188,666 | - |
| 190 | SGP | SpyGlass Pharma, Inc. | 699.62M | -5.08% | 46,516 | - |
| 191 | DSGN | Design Therapeutics, Inc. | 697.64M | 1.45% | 705,105 | - |
| 192 | ALLO | Allogene Therapeutics, Inc. | 688.58M | 1.79% | 3,431,063 | 22.00K |
| 193 | CBIO | Crescent Biopharma, Inc. | 687.34M | 2.25% | 112,140 | 11.88M |
| 194 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 685.08M | -6.04% | 516,564 | - |
| 195 | SLDB | Solid Biosciences Inc. | 655.18M | 2.38% | 719,764 | - |
| 196 | ACRS | Aclaris Therapeutics, Inc. | 631.28M | -0.44% | 389,949 | 8.37M |
| 197 | CRMD | CorMedix Inc. | 627.62M | -0.74% | 495,751 | 400.05M |
| 198 | IMMX | Immix Biopharma, Inc. | 607.18M | 0.35% | 2,185,092 | - |
| 199 | EIKN | Eikon Therapeutics, Inc. | 599.86M | -0.72% | 136,057 | - |
| 200 | TRAX | First Tracks Biotherapeutics, Inc. | 595.61M | 1.85% | 242,445 | - |
| 201 | ZVRA | Zevra Therapeutics, Inc. | 595.29M | -4.00% | 807,643 | 122.29M |
| 202 | CABA | Cabaletta Bio, Inc. | 589.43M | -2.03% | 1,819,389 | - |
| 203 | CADL | Candel Therapeutics, Inc. | 587.63M | 1.13% | 1,328,443 | - |
| 204 | ARVN | Arvinas, Inc. | 587.14M | - | 529,046 | 89.40M |
| 205 | ALT | Altimmune, Inc. | 563.00M | -1.19% | 1,425,098 | 36.00K |
| 206 | AGMB | AgomAb Therapeutics NV | 558.96M | 3.75% | 23,441 | - |
| 207 | GYRE | Gyre Therapeutics, Inc. | 554.63M | -1.78% | 69,000 | 117.05M |
| 208 | DNA | Ginkgo Bioworks Holdings, Inc. | 552.65M | 4.70% | 666,175 | 151.40M |
| 209 | TECX | Tectonic Therapeutic, Inc. | 545.51M | 1.37% | 63,752 | - |
| 210 | VALN | Valneva SE | 543.39M | 1.19% | 56,112 | 180.25M |
| 211 | PRME | Prime Medicine, Inc. | 537.34M | 0.85% | 1,729,581 | 4.03M |
| 212 | RIGL | Rigel Pharmaceuticals, Inc. | 537.12M | -0.55% | 115,685 | 299.77M |
| 213 | MDXG | MiMedx Group, Inc. | 536.95M | -0.14% | 601,602 | 389.42M |
| 214 | FBRX | Forte Biosciences, Inc. | 528.30M | -1.73% | 95,254 | - |
| 215 | CLYM | Climb Bio, Inc. | 525.45M | 0.82% | 349,301 | - |
| 216 | PROK | ProKidney Corp. | 523.90M | -0.86% | 421,704 | 889.00K |
| 217 | XOMA | XOMA Royalty Corporation | 522.71M | -0.33% | 87,364 | 48.56M |
| 218 | KYTX | Kyverna Therapeutics, Inc. | 522.38M | -3.03% | 373,919 | - |
| 219 | CTNM | Contineum Therapeutics, Inc. | 522.10M | -2.82% | 169,547 | - |
| 220 | PRTA | Prothena Corporation plc | 514.11M | 4.36% | 389,016 | 57.94M |
| 221 | ACHV | Achieve Life Sciences, Inc. | 479.42M | 1.52% | 649,043 | - |
| 222 | ANL | Adlai Nortye Ltd. | 476.00M | 2.94% | 20,924 | 5.00M |
| 223 | STTK | Shattuck Labs, Inc. | 468.52M | 0.33% | 248,247 | 1.00M |
| 224 | EPRX | Eupraxia Pharmaceuticals Inc. | 461.05M | 1.73% | 810,601 | - |
| 225 | AUTL | Autolus Therapeutics plc | 457.77M | 4.24% | 906,452 | 92.62M |
| 226 | UPB | Upstream Bio, Inc. | 453.86M | -1.42% | 161,221 | 3.32M |
| 227 | OCGN | Ocugen, Inc. | 453.62M | -0.74% | 3,177,138 | 4.47M |
| 228 | ASMB | Assembly Biosciences, Inc. | 448.97M | 6.60% | 770,907 | 71.10M |
| 229 | FDMT | 4D Molecular Therapeutics, Inc. | 448.53M | -1.27% | 318,831 | 88.24M |
| 230 | SGMT | Sagimet Biosciences Inc. | 440.29M | 1.86% | 724,157 | - |
| 231 | FULC | Fulcrum Therapeutics, Inc. | 436.78M | -0.53% | 180,448 | 80.00M |
| 232 | NGNE | Neurogene Inc. | 436.13M | -0.04% | 52,242 | 925.00K |
| 233 | STRO | Sutro Biopharma, Inc. | 433.58M | -14.53% | 610,122 | 99.61M |
| 234 | VTVT | vTv Therapeutics Inc. | 430.61M | -2.25% | 55,581 | 36.84M |
| 235 | ADCT | ADC Therapeutics SA | 427.36M | -1.18% | 302,764 | 79.18M |
| 236 | OVID | Ovid Therapeutics Inc. | 425.67M | 0.82% | 1,174,486 | 7.12M |
| 237 | PRLD | Prelude Therapeutics Incorporated | 420.42M | -3.46% | 192,841 | 16.72M |
| 238 | MNPR | Monopar Therapeutics Inc. | 419.81M | -0.02% | 72,882 | - |
| 239 | ZURA | Zura Bio Limited | 414.63M | -1.58% | 416,868 | - |
| 240 | IPSC | Century Therapeutics, Inc. | 408.50M | -0.22% | 451,976 | 109.16M |
| 241 | LYEL | Lyell Immunopharma, Inc. | 406.01M | 0.58% | 30,858 | 31.00K |
| 242 | ENTA | Enanta Pharmaceuticals, Inc. | 405.93M | 0.94% | 91,457 | 69.21M |
| 243 | REPL | Replimune Group, Inc. | 403.78M | -6.32% | 2,256,657 | - |
| 244 | LXEO | Lexeo Therapeutics, Inc. | 402.03M | -2.10% | 297,609 | - |
| 245 | CCCC | C4 Therapeutics, Inc. | 398.30M | 2.70% | 1,417,164 | 34.86M |
| 246 | IFRX | InflaRx N.V. | 389.59M | 7.09% | 981,784 | 33.82K |
| 247 | BNTC | Benitec Biopharma Inc. | 389.58M | -0.18% | 78,900 | - |
| 248 | GLSI | Greenwich LifeSciences, Inc. | 386.54M | 2.61% | 62,062 | - |
| 249 | OABI | OmniAb, Inc. | 382.00M | 3.33% | 579,715 | 28.94M |
| 250 | XFOR | X4 Pharmaceuticals, Inc. | 377.75M | -0.87% | 133,373 | 9.01M |
| 251 | ARTV | Artiva Biotherapeutics, Inc. | 376.07M | -3.13% | 194,812 | 251.00K |
| 252 | CMPX | Compass Therapeutics, Inc. | 371.88M | 6.99% | 5,151,327 | 850.00K |
| 253 | VSTM | Verastem, Inc. | 371.71M | -0.94% | 1,043,534 | 49.59M |
| 254 | VNDA | Vanda Pharmaceuticals Inc. | 369.83M | -0.97% | 680,534 | 217.78M |
| 255 | LRMR | Larimar Therapeutics, Inc. | 360.12M | -3.36% | 827,789 | - |
| 256 | PBYI | Puma Biotechnology, Inc. | 359.35M | 0.14% | 124,776 | 227.18M |
| 257 | AVIR | Atea Pharmaceuticals, Inc. | 352.52M | 3.89% | 218,203 | - |
| 258 | IMRX | Immuneering Corporation | 346.13M | 2.49% | 9,849,559 | - |
| 259 | FENC | Fennec Pharmaceuticals Inc. | 344.94M | -0.40% | 151,305 | 51.00M |
| 260 | RZLT | Rezolute, Inc. | 340.04M | -2.54% | 641,486 | - |
| 261 | NMRA | Neumora Therapeutics, Inc. | 334.32M | -1.08% | 1,128,999 | - |
| 262 | PALI | Palisade Bio, Inc. | 334.01M | -0.75% | 2,859,427 | - |
| 263 | RGNX | REGENXBIO Inc. | 326.73M | -6.37% | 1,198,522 | 87.82M |
| 264 | LCTX | Lineage Cell Therapeutics, Inc. | 325.33M | -1.14% | 396,973 | 14.78M |
| 265 | IVVD | Invivyd, Inc. | 324.07M | -0.90% | 1,322,489 | 55.87M |
| 266 | YDES | YD Bio Limited | 323.47M | 1.77% | 2,088 | 510.36K |
| 267 | RCKT | Rocket Pharmaceuticals, Inc. | 322.67M | -4.98% | 1,760,640 | - |
| 268 | NAUT | Nautilus Biotechnology, Inc. | 322.14M | -0.20% | 336,499 | - |
| 269 | DMAC | DiaMedica Therapeutics Inc. | 320.34M | 3.03% | 46,104 | - |
| 270 | BCYC | Bicycle Therapeutics plc | 317.86M | 2.47% | 248,685 | 63.50M |
| 271 | ABEO | Abeona Therapeutics Inc. | 308.91M | -1.81% | 550,612 | 14.54M |
| 272 | IRD | Opus Genetics, Inc. | 305.60M | -0.23% | 447,710 | 11.98M |
| 273 | ARMP | Armata Pharmaceuticals, Inc. | 305.30M | 1.09% | 33,860 | 5.20M |
| 274 | SRZN | Surrozen, Inc. | 304.40M | -2.18% | 43,557 | 7.49M |
| 275 | ELDN | Eledon Pharmaceuticals, Inc. | 300.71M | - | 522,204 | - |
| 276 | NAGE | Niagen Bioscience, Inc. | 295.30M | -2.37% | 557,541 | 130.42M |
| 277 | SLN | Silence Therapeutics plc | 293.80M | -4.16% | 219,078 | 839.00K |
| 278 | IKT | Inhibikase Therapeutics, Inc. | 291.42M | -1.72% | 371,215 | 1.00 |
| 279 | ZNTL | Zentalis Pharmaceuticals, Inc. | 288.30M | -2.17% | 461,659 | 26.87M |
| 280 | ACIU | AC Immune SA | 283.22M | 0.18% | 59,188 | 4.62M |
| 281 | MGNX | MacroGenics, Inc. | 281.57M | 4.48% | 923,296 | 157.08M |
| 282 | SABS | SAB Biotherapeutics, Inc. | 274.08M | 2.36% | 276,624 | 114.70K |
| 283 | NVCT | Nuvectis Pharma, Inc. | 273.74M | -5.67% | 129,187 | - |
| 284 | TARA | Protara Therapeutics, Inc. | 272.87M | -2.31% | 702,476 | - |
| 285 | EDIT | Editas Medicine, Inc. | 268.26M | 2.62% | 880,269 | 38.69M |
| 286 | ALXO | ALX Oncology Holdings Inc. | 267.77M | - | 1,083,712 | - |
| 287 | FATE | Fate Therapeutics, Inc. | 266.92M | 9.05% | 5,042,380 | 6.32M |
| 288 | CGEN | Compugen Ltd. | 266.26M | 7.85% | 521,476 | 72.66M |
| 289 | CLLS | Cellectis S.A. | 257.53M | - | 12,426 | 75.11M |
| 290 | AVXL | Anavex Life Sciences Corp. | 248.36M | -1.11% | 893,304 | - |
| 291 | FHTX | Foghorn Therapeutics Inc. | 248.36M | 1.68% | 136,939 | 28.22M |
| 292 | CHRS | Coherus Oncology, Inc. | 247.57M | 2.23% | 728,569 | 46.88M |
| 293 | ADAG | Adagene Inc. | 246.45M | -1.58% | 49,997 | 7.67M |
| 294 | NERV | Minerva Neurosciences, Inc. | 245.99M | -0.38% | 45,892 | - |
| 295 | ALEC | Alector, Inc. | 244.81M | -0.23% | 225,772 | 18.42M |
| 296 | OBIO | Orchestra BioMed Holdings, Inc. | 243.42M | -0.85% | 168,281 | 32.72M |
| 297 | CAMP | Camp4 Therapeutics Corporation | 238.86M | 4.55% | 32,757 | 3.93M |
| 298 | SLGL | Sol-Gel Technologies Ltd. | 238.46M | 6.79% | 74,461 | 19.39M |
| 299 | LENZ | LENZ Therapeutics, Inc. | 238.29M | 1.06% | 307,912 | 20.99M |
| 300 | CNTX | Context Therapeutics Inc. | 237.05M | 7.50% | 1,784,424 | - |
| 301 | TRDA | Entrada Therapeutics, Inc. | 233.50M | 2.69% | 261,854 | 5.74M |
| 302 | HELP | Cybin Inc. | 233.17M | 1.30% | 500,652 | - |
| 303 | HUMA | Humacyte, Inc. | 229.79M | 1.47% | 3,341,071 | 2.02M |
| 304 | VYGR | Voyager Therapeutics, Inc. | 229.60M | 3.26% | 472,349 | 36.49M |
| 305 | CDXS | Codexis, Inc. | 225.42M | -1.98% | 678,662 | 78.09M |
| 306 | RNA | Atrium Therapeutics, Inc. | 224.25M | 0.54% | 130,300 | 36.68M |
| 307 | KROS | Keros Therapeutics, Inc. | 221.47M | -0.27% | 178,623 | 33.18M |
| 308 | WHWK | Whitehawk Therapeutics, Inc. | 220.94M | 3.95% | 308,537 | 7.15M |
| 309 | NKTX | Nkarta, Inc. | 217.50M | 0.33% | 281,700 | - |
| 310 | UNCY | Unicycive Therapeutics, Inc. | 216.27M | 6.16% | 532,321 | - |
| 311 | MDWD | MediWound Ltd. | 213.09M | -1.54% | 13,673 | 16.96M |
| 312 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 208.23M | 2.00% | 474,705 | - |
| 313 | TNXP | Tonix Pharmaceuticals Holding Corp. | 204.84M | -8.21% | 519,386 | 17.56M |
| 314 | CRBU | Caribou Biosciences, Inc. | 204.38M | 4.52% | 1,218,396 | 11.20M |
| 315 | NBP | NovaBridge Biosciences | 204.12M | -0.84% | 718,848 | - |
| 316 | CNTN | Canton Strategic Holdings, Inc. | 200.00M | 5.37% | 508,209 | - |
| 317 | ARCT | Arcturus Therapeutics Holdings Inc. | 199.53M | - | 199,036 | 54.71M |
| 318 | RNAC | Cartesian Therapeutics, Inc. | 198.91M | 1.35% | 88,707 | 1.78M |
| 319 | IPHA | Innate Pharma S.A. | 195.68M | -7.10% | 11,277 | 10.57M |
| 320 | MIST | Milestone Pharmaceuticals Inc. | 195.23M | -5.59% | 1,086,316 | 1.78M |
| 321 | TLSA | Tiziana Life Sciences Ltd | 188.25M | 1.03% | 548,215 | - |
| 322 | DTIL | Precision BioSciences, Inc. | 187.07M | 1.40% | 148,068 | 45.07M |
| 323 | ELTX | Elicio Therapeutics, Inc. | 183.22M | 0.61% | 99,999 | - |
| 324 | KPTI | Karyopharm Therapeutics Inc. | 182.67M | 0.50% | 207,370 | 151.12M |
| 325 | ABOS | Acumen Pharmaceuticals, Inc. | 181.65M | 1.00% | 338,994 | - |
| 326 | IMUX | Immunic, Inc. | 176.33M | 5.24% | 285,827 | - |
| 327 | ANTX | AN2 Therapeutics, Inc. | 175.30M | -0.41% | 690,949 | - |
| 328 | ENLV | Enlivex Ltd. | 174.16M | 0.32% | 104,237 | - |
| 329 | TNYA | Tenaya Therapeutics, Inc. | 172.04M | 0.35% | 1,388,643 | 225.00K |
| 330 | KRRO | Korro Bio, Inc. | 170.91M | 5.80% | 180,555 | 3.84M |
| 331 | PLYX | Polaryx Therapeutics, Inc. | 170.44M | -8.63% | 141,096 | - |
| 332 | OKUR | OnKure Therapeutics, Inc. | 169.66M | 3.19% | 228,239 | - |
| 333 | NGEN | NervGen Pharma Corp. | 168.74M | -43.34% | 11,171,499 | - |
| 334 | PLX | Protalix BioTherapeutics, Inc. | 168.39M | 2.96% | 537,685 | 76.38M |
| 335 | GALT | Galectin Therapeutics Inc. | 166.21M | 0.20% | 268,756 | - |
| 336 | ORMP | Oramed Pharmaceuticals Inc. | 164.62M | -7.08% | 123,473 | 2.00M |
| 337 | HRTX | Heron Therapeutics, Inc. | 164.18M | -0.44% | 814,861 | 150.71M |
| 338 | MENS | Jyong Biotech Ltd. | 163.80M | 2.40% | 37,297 | - |
| 339 | PRQR | ProQR Therapeutics N.V. | 161.73M | 6.60% | 478,692 | 15.73M |
| 340 | SPRO | Spero Therapeutics, Inc. | 160.97M | 3.35% | 491,282 | 61.19M |
| 341 | HURA | TuHURA Biosciences, Inc. | 157.93M | 5.98% | 536,333 | - |
| 342 | KZIA | Kazia Therapeutics Limited | 157.81M | 4.86% | 151,873 | 1.27M |
| 343 | TTRX | Turn Therapeutics Inc. | 154.00M | 4.02% | 30,202 | - |
| 344 | GUTS | Fractyl Health, Inc. | 141.20M | -3.26% | 1,733,665 | 3.00K |
| 345 | SPRB | Spruce Biosciences, Inc. | 140.11M | -1.61% | 63,683 | 697.00K |
| 346 | EQ | Equillium, Inc. | 139.73M | - | 434,904 | 4.39M |
| 347 | NTHI | NeOnc Technologies Holdings, Inc. | 137.97M | 1.68% | 78,643 | 39.99K |
| 348 | MOLN | Molecular Partners AG | 136.52M | 10.00% | 10,281 | 856.30K |
| 349 | CNTB | Connect Biopharma Holdings Limited | 132.26M | -0.85% | 87,127 | 233.00K |
| 350 | BDTX | Black Diamond Therapeutics, Inc. | 130.08M | -36.06% | 7,296,667 | 70.00M |
| 351 | ACOG | Alpha Cognition Inc. | 128.68M | 1.55% | 28,223 | 10.83M |
| 352 | GNLX | Genelux Corporation | 127.90M | -1.37% | 64,224 | 8.00K |
| 353 | AGEN | Agenus Inc. | 127.11M | -3.16% | 731,098 | 123.87M |
| 354 | PYXS | Pyxis Oncology, Inc. | 125.44M | 2.06% | 909,070 | 13.86M |
| 355 | NRXP | NRx Pharmaceuticals, Inc. | 118.18M | 6.70% | 1,290,713 | 2.29M |
| 356 | CRDF | Cardiff Oncology, Inc. | 117.60M | -3.91% | 1,054,597 | 525.00K |
| 357 | ALPS | Alps Group Inc | 116.48M | - | 33,656 | 3.74M |
| 358 | COYA | Coya Therapeutics, Inc. | 113.06M | -0.41% | 70,475 | 7.94M |
| 359 | CGTX | Cognition Therapeutics, Inc. | 111.37M | -0.28% | 457,160 | - |
| 360 | KLRS | Kalaris Therapeutics, Inc. | 111.05M | -5.66% | 80,575 | - |
| 361 | INO | Inovio Pharmaceuticals, Inc. | 111.03M | 1.88% | 3,012,684 | 65.34K |
| 362 | ENGN | enGene Therapeutics Inc. | 110.87M | -4.34% | 998,235 | - |
| 363 | RANI | Rani Therapeutics Holdings, Inc. | 106.30M | -0.47% | 676,078 | 3.17M |
| 364 | VRCA | Verrica Pharmaceuticals Inc. | 105.91M | 4.49% | 67,386 | 37.16M |
| 365 | CBUS | Cibus, Inc. | 105.27M | - | 265,295 | 4.29M |
| 366 | PEPG | PepGen Inc. | 104.10M | -2.27% | 475,897 | - |
| 367 | BMEA | Biomea Fusion, Inc. | 103.03M | 4.01% | 806,602 | - |
| 368 | VANI | Vivani Medical, Inc. | 101.76M | 1.72% | 347,678 | - |
| 369 | LONA | LeonaBio, Inc. | 100.42M | 6.16% | 17,116 | - |
| 370 | QTTB | Q32 Bio Inc. | 99.87M | 7.09% | 587,333 | 53.74M |
| 371 | SEER | Seer, Inc. | 99.86M | - | 495,613 | 15.17M |
| 372 | AARD | Aardvark Therapeutics, Inc. | 98.50M | 0.11% | 118,912 | - |
| 373 | PMN | ProMIS Neurosciences, Inc. | 96.85M | -0.46% | 22,134 | - |
| 374 | ANVS | Annovis Bio, Inc. | 95.72M | 4.65% | 2,133,598 | - |
| 375 | PYPD | PolyPid Ltd. | 95.23M | 3.31% | 190,772 | - |
| 376 | ONCY | Oncolytics Biotech Inc. | 94.08M | 2.54% | 539,442 | - |
| 377 | EDSA | Edesa Biotech, Inc. | 94.01M | -2.67% | 100,899 | - |
| 378 | ALDX | Aldeyra Therapeutics, Inc. | 93.20M | -2.83% | 327,165 | - |
| 379 | PTHS | Pelthos Therapeutics Inc. | 92.97M | -1.29% | 10,791 | 27.70M |
| 380 | FBIO | Fortress Biotech, Inc. | 92.85M | 0.54% | 257,980 | 66.16M |
| 381 | ANIX | Anixa Biosciences, Inc. | 92.37M | 0.18% | 31,378 | - |
| 382 | ICCC | ImmuCell Corporation | 92.19M | 1.80% | 21,227 | 29.93M |
| 383 | RNTX | Rein Therapeutics Inc. | 88.96M | - | 348,710 | - |
| 384 | OKYO | OKYO Pharma Limited | 87.64M | -0.60% | 42,022 | - |
| 385 | ACET | Adicet Bio, Inc. | 85.95M | 3.74% | 78,812 | - |
| 386 | EXOZ | eXoZymes, Inc. | 84.11M | 5.53% | 17,328 | -700.00 |
| 387 | NRXS | NeurAxis, Inc. | 83.99M | -1.75% | 81,190 | 4.28M |
| 388 | HYFT | MindWalk Holdings Corp. | 83.44M | 9.09% | 1,676,450 | 20.70M |
| 389 | ATRA | Atara Biotherapeutics, Inc. | 82.99M | 4.39% | 97,981 | 23.14M |
| 390 | RLYB | Rallybio Corporation | 82.94M | 1.95% | 45,846 | 858.00K |
| 391 | CSBR | Champions Oncology, Inc. | 80.13M | -3.03% | 8,690 | 57.95M |
| 392 | MAIA | MAIA Biotechnology, Inc. | 78.43M | 0.78% | 228,542 | - |
| 393 | ATHE | Alterity Therapeutics Limited | 77.52M | 0.48% | 35,298 | 4.43M |
| 394 | MCRB | Seres Therapeutics, Inc. | 76.60M | -1.74% | 18,559 | 1.15M |
| 395 | GANX | Gain Therapeutics, Inc. | 75.92M | 1.71% | 380,318 | - |
| 396 | ACRV | Acrivon Therapeutics, Inc. | 75.54M | -1.40% | 769,825 | - |
| 397 | PLRX | Pliant Therapeutics, Inc. | 75.54M | -0.81% | 170,967 | - |
| 398 | XBIT | XBiotech Inc. | 74.09M | -2.02% | 12,819 | - |
| 399 | OSTX | OS Therapies Incorporated | 72.94M | -4.67% | 289,038 | - |
| 400 | TCRX | TScan Therapeutics, Inc. | 70.51M | 5.77% | 616,283 | 9.14M |
| 401 | CUE | Cue Biopharma, Inc. | 70.16M | 7.23% | 56,490 | 32.73M |
| 402 | PDSB | PDS Biotechnology Corporation | 68.65M | 6.03% | 1,053,331 | - |
| 403 | MNOV | MediciNova, Inc. | 68.42M | 1.46% | 8,188 | 596.64K |
| 404 | PMVP | PMV Pharmaceuticals, Inc. | 66.66M | -2.34% | 111,741 | - |
| 405 | IBIO | iBio, Inc. | 66.14M | -3.17% | 537,388 | 300.00K |
| 406 | LIXT | Lixte Biotechnology Holdings, Inc. | 65.06M | -5.25% | 130,022 | - |
| 407 | BYSI | BeyondSpring Inc. | 64.15M | 8.33% | 38,224 | 1.88M |
| 408 | FLNA | Filana Therapeutics, Inc. | 63.52M | 1.94% | 213,270 | - |
| 409 | IMA | ImageneBio, Inc. | 63.16M | 1.45% | 8,514 | 800.00K |
| 410 | IMMP | Immutep Limited | 63.03M | 2.00% | 335,591 | 5.28M |
| 411 | DWTX | Dogwood Therapeutics, Inc. | 60.62M | 0.28% | 17,862 | - |
| 412 | ENTX | Entera Bio Ltd. | 60.05M | -3.94% | 21,864 | 42.00K |
| 413 | CING | Cingulate Inc. | 59.21M | -5.91% | 386,635 | - |
| 414 | ACTU | Actuate Therapeutics, Inc. | 56.47M | -2.48% | 46,891 | - |
| 415 | IBO | Impact BioMedical Inc. | 55.99M | -2.38% | 23,225 | 39.00K |
| 416 | TIL | Instil Bio, Inc. | 55.29M | 0.40% | 10,846 | - |
| 417 | INKT | MiNK Therapeutics, Inc. | 54.35M | -0.27% | 38,529 | - |
| 418 | RADX | Radiopharm Theranostics Limited | 53.05M | 0.65% | 13,927 | 10.86M |
| 419 | HYPD | Hyperion DeFi, Inc. | 51.92M | -6.28% | 497,822 | 1.04M |
| 420 | MGX | Metagenomi Therapeutics, Inc. | 51.20M | 3.82% | 163,314 | 22.33M |
| 421 | ESLA | Estrella Immunopharma, Inc. | 48.85M | 1.33% | 25,565 | - |
| 422 | XLO | Xilio Therapeutics, Inc. | 48.76M | -4.96% | 47,434 | 53.48M |
| 423 | ATYR | aTyr Pharma, Inc. | 48.67M | -6.07% | 2,771,493 | 190.00K |
| 424 | GOSS | Gossamer Bio, Inc. | 48.65M | 3.19% | 11,180,559 | 55.54M |
| 425 | PSTV | Plus Therapeutics, Inc. | 45.98M | -2.76% | 112,956 | 5.18M |
| 426 | KALA | KALA BIO, Inc. | 45.92M | -5.00% | 47,784 | - |
| 427 | MREO | Mereo BioPharma Group plc | 44.87M | 3.31% | 1,780,003 | 500.00K |
| 428 | QNTM | Quantum BioPharma Ltd. | 44.73M | 18.44% | 709,784 | - |
| 429 | TELO | Telomir Pharmaceuticals, Inc. | 43.66M | -2.31% | 50,924 | - |
| 430 | NTRB | Nutriband Inc. | 43.03M | 1.43% | 3,931 | 2.04M |
| 431 | ATOS | Atossa Therapeutics, Inc. | 42.21M | -1.39% | 23,805 | - |
| 432 | TVGN | Tevogen Bio Holdings Inc. | 41.04M | -15.26% | 44,598 | - |
| 433 | RNXT | RenovoRx, Inc. | 40.04M | 0.82% | 148,700 | 1.49M |
| 434 | LTRN | Lantern Pharma Inc. | 39.90M | 7.23% | 413,662 | - |
| 435 | LITS | Lite Strategy, Inc. | 39.09M | -2.27% | 852,127 | - |
| 436 | INMB | INmune Bio Inc. | 38.15M | -0.35% | 138,179 | 50.00K |
| 437 | OTLK | Outlook Therapeutics, Inc. | 38.01M | -5.56% | 7,515,085 | 333.14K |
| 438 | VERU | Veru Inc. | 37.56M | 5.41% | 83,683 | 16.89M |
| 439 | NNVC | NanoViricides, Inc. | 37.47M | 6.13% | 688,314 | - |
| 440 | ATNM | Actinium Pharmaceuticals, Inc. | 36.48M | -0.85% | 50,204 | 90.00K |
| 441 | ALGS | Aligos Therapeutics, Inc. | 35.40M | 0.18% | 129,282 | 4.71M |
| 442 | DARE | Daré Bioscience, Inc. | 35.35M | -2.07% | 399,086 | 1.16M |
| 443 | EVAX | Evaxion A/S | 34.36M | 1.48% | 23,776 | 7.53M |
| 444 | GRCE | Grace Therapeutics, Inc. | 34.20M | -1.34% | 234,860 | - |
| 445 | TVRD | Tvardi Therapeutics, Inc. | 33.68M | - | 44,925 | - |
| 446 | APLM | Apollomics, Inc. | 32.55M | 3.57% | 7,009 | 8.84M |
| 447 | BOLD | Boundless Bio, Inc. | 32.28M | -0.69% | 68,944 | - |
| 448 | SNTI | Senti Biosciences Holdings, Inc. | 30.91M | 0.84% | 143,054 | 38.00K |
| 449 | GRDX | GridAI Technologies Corp. | 30.60M | 7.05% | 174,927 | - |
| 450 | SER | Serina Therapeutics, Inc. | 29.65M | 5.46% | 174,084 | 130.00K |
| 451 | SKYE | Skye Bioscience, Inc. | 29.05M | 15.70% | 199,080 | - |
| 452 | NEUP | Neuphoria Therapeutics Inc. | 28.84M | 4.49% | 127,204 | -13.27K |
| 453 | LSTA | Lisata Therapeutics, Inc. | 28.81M | 1.59% | 1,464 | 170.00K |
| 454 | NRSN | NeuroSense Therapeutics Ltd. | 28.81M | 5.44% | 47,209 | - |
| 455 | CRVO | CervoMed Inc. | 28.70M | 0.32% | 64,166 | 2.09M |
| 456 | KYNB | Kyntra Bio, Inc. | 28.26M | 0.58% | 10,777 | 7.44M |
| 457 | NXTC | NextCure, Inc. | 28.25M | -23.24% | 89,624 | - |
| 458 | IGC | IGC Pharma, Inc. | 28.25M | -1.04% | 3,930,671 | 1.11M |
| 459 | BRNS | Barinthus Biotherapeutics plc | 28.06M | -1.98% | 7,690 | 14.97M |
| 460 | PLRZ | Polyrizon Ltd. | 27.61M | 16.60% | 41,328 | - |
| 461 | DYAI | Dyadic International, Inc. | 27.46M | 1.85% | 208,498 | 3.81M |
| 462 | TPST | Tempest Therapeutics, Inc. | 27.39M | 5.51% | 32,762 | - |
| 463 | ALLR | Allarity Therapeutics, Inc. | 27.06M | 5.42% | 246,740 | 345.00K |
| 464 | ABVC | ABVC BioPharma, Inc. | 26.93M | -1.80% | 221,475 | 797.92K |
| 465 | BCTX | BriaCell Therapeutics Corp. | 26.56M | -7.26% | 471,859 | - |
| 466 | CLRB | Cellectar Biosciences, Inc. | 26.21M | 3.47% | 122,854 | - |
| 467 | VTGN | Vistagen Therapeutics, Inc. | 25.75M | 2.02% | 518,282 | 789.00K |
| 468 | CELU | Celularity Inc. | 25.62M | -1.14% | 92,852 | 26.55M |
| 469 | JSPR | Jasper Therapeutics, Inc. | 25.55M | 4.57% | 667,435 | - |
| 470 | PTN | Palatin Technologies, Inc. | 25.18M | 2.08% | 8,315 | 12.88M |
| 471 | PLUR | Pluri Inc. | 25.01M | 8.19% | 4,621 | 1.08M |
| 472 | SNSE | Sensei Biotherapeutics, Inc. | 24.32M | 3.19% | 16,447 | - |
| 473 | LGVN | Longeveron Inc. | 23.72M | 12.33% | 265,994 | 1.22M |
| 474 | MRKR | Marker Therapeutics, Inc. | 23.68M | -0.70% | 59,173 | 3.55M |
| 475 | TRAW | Traws Pharma, Inc. | 22.73M | 0.67% | 725,174 | 2.73M |
| 476 | VYNE | VYNE Therapeutics Inc. | 22.43M | -0.72% | 59,465 | 454.00K |
| 477 | HOWL | Werewolf Therapeutics, Inc. | 21.89M | 6.62% | 579,212 | 1.14M |
| 478 | CVM | CEL-SCI Corporation | 20.87M | -0.69% | 243,322 | - |
| 479 | MTVA | MetaVia Inc. | 20.40M | 37.63% | 39,435,894 | - |
| 480 | AEON | AEON Biopharma, Inc. | 20.29M | -6.09% | 107,390 | - |
| 481 | CRIS | Curis, Inc. | 20.01M | 2.14% | 92,866 | 7.06M |
| 482 | HCWB | HCW Biologics Inc. | 20.00M | 15.12% | 18,998,366 | 6.59M |
| 483 | CTXR | Citius Pharmaceuticals, Inc. | 18.98M | 4.03% | 396,295 | 5.61M |
| 484 | AKTX | Akari Therapeutics, Plc | 18.67M | 221.01% | 29,978,224 | - |
| 485 | LPCN | Lipocine Inc. | 18.14M | 1.80% | 48,673 | 2.00M |
| 486 | QNCX | Quince Therapeutics, Inc. | 17.52M | 0.47% | 806,620 | - |
| 487 | KTTA | Pasithea Therapeutics Corp. | 17.49M | -2.76% | 307,910 | - |
| 488 | XCUR | Exicure, Inc. | 17.40M | -1.08% | 13,585 | 500.00K |
| 489 | NCEL | NewcelX Ltd. | 17.39M | 1.57% | 11,395 | - |
| 490 | OSRH | OSR Holdings, Inc. | 16.77M | -0.76% | 556,281 | 2.63M |
| 491 | PASG | Passage Bio, Inc. | 16.65M | 0.58% | 9,437 | - |
| 492 | INAB | IN8bio, Inc. | 16.25M | -1.79% | 79,717 | - |
| 493 | CVKD | Cadrenal Therapeutics, Inc. | 16.01M | 0.58% | 99,529 | - |
| 494 | COCP | Cocrystal Pharma, Inc. | 15.99M | 2.65% | 45,440 | 225.00K |
| 495 | LEXX | Lexaria Bioscience Corp. | 15.99M | 6.51% | 98,477 | 368.00K |
| 496 | HIND | Vyome Holdings, Inc. | 15.65M | - | 15,392 | 152.72K |
| 497 | ICU | SeaStar Medical Holding Corporation | 15.07M | -4.80% | 127,125 | 1.44M |
| 498 | GTBP | GT Biopharma, Inc. | 14.51M | 6.24% | 2,308,357 | - |
| 499 | CMMB | Chemomab Therapeutics Ltd. | 14.33M | 9.34% | 83,652 | - |
| 500 | GNTA | Genenta Science S.p.A. | 14.12M | 1.47% | 60,538 | - |